Skip to Main Content

Paper Details

Discovery of biomarkers for glycaemic deterioration before and after the onset of type 2 diabetes: descriptive characteristics of the epidemiological studies within the IMI DIRECT Consortium.
Diabetologia
18
2019
Diabetes, Patient, diabetes, glucose, glycaemic deterioration, metformin, participants, patients, people, prediabetes, type 2 diabetes
Author NameAffiliation
Ana ViñuelaUniversity of Geneva Medical School
Ana Viñuela
Ana ViñuelaInstitute of Genetics and Genomics in Geneva (iGE3), University of Geneva
Christopher J GrovesUniversity of Oxford
Anubha MahajanUniversity of Oxford
Martin RidderstråleClinical Obesity, Skane University Hospital Malmo, Lund University
Martin Ridderstråle
S??ren BrunakTechnical University of Denmark
S??ren BrunakThe Novo Nordisk Foundation Center for Protein Research, University of Copenhagen
S??ren BrunakTechnical University of Denmark
S??ren BrunakThe Novo Nordisk Foundation Center for Protein Research, University of Copenhagen
Emmanouil T DermitzakisUniversity of Geneva Medical School
Emmanouil T Dermitzakis
Emmanouil T DermitzakisInstitute of Genetics and Genomics in Geneva (iGE3), University of Geneva
Emmanouil T DermitzakisUniversity of Geneva Medical School
Emmanouil T DermitzakisInstitute of Genetics and Genomics in Geneva (iGE3), University of Geneva
Emmanouil T Dermitzakis
Philippe FroguelSchool of Public Health, Imperial College London
Philippe FroguelCNRS, Pasteur Institute of Lille, University of Lille
Torben HansenThe Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen
Torben HansenUniversity of Southern Denmark
Andrew T HattersleyNIHR Exeter Clinical Research Facility, University of Exeter Medical School
Andrew T HattersleyInstitute of Biomedical and Clinical Science, University of Exeter Medical School
Jane KayeUniversity of Oxford
Markku LaaksoUniversity of Eastern Finland and Kuopio University Hospital
Oluf PedersenThe Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen
Jochen M SchwenkKTH - Royal Institute of Technology
Jochen M SchwenkKTH - Royal Institute of Technology
Timothy M FraylingUniversity of Oxford
Timothy M FraylingUniversity of Oxford
Timothy M FraylingNIHR Oxford Biomedical Research Centre, Churchill Hospital
Andrew T HattersleyInstitute of Cellular Medicine (Diabetes), Newcastle University
Paul W FranksLund University Diabetes Centre, Skane University Hospital Malmo
Paul W FranksUniversity of Oxford
Paul W FranksHarvard School of Public Health
Paul W FranksDepartment of Public Health & Clinical Medicine, Umea University
  • 1 - 36

Datasets